DERMATA THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-7.6M | $-12.3M | $-7.8M | $-9.6M | $-7.9M | $-3.2M |
| Depreciation & Amortization | — | — | — | — | $0 | $322 |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $143.7K | $657.6K | $522.1K | $930.3K | $1.9M | $0 |
| Net Cash from Operating Activities | $-7.8M | $-11.2M | $-6.4M | $-8.8M | $-5.7M | $-4.0M |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.1M | $6.9M | $7.6M | $4.3M | $16.0M | $2.6M |
| Net Change in Cash | $4.4M | $-4.3M | — | — | $10.3M | $-1.5M |
| Free Cash Flow | — | — | — | — | — | — |